ArticlePloS one2021

A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.

Alcibiade Athanasiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.